Document is current
Any future updates will be listed below
-
Authors
Bergman, Drew T. https://orcid.org/0000-0002-8314-7088
Jones, Thouis R.
Liu, Vincent https://orcid.org/0000-0002-6790-6603
Ray, Judhajeet https://orcid.org/0000-0003-1524-2603
Jagoda, Evelyn
Siraj, Layla
Kang, Helen Y.
Nasser, Joseph
Kane, Michael
Rios, Antonio https://orcid.org/0000-0002-6717-2267
Nguyen, Tung H.
Grossman, Sharon R.
Fulco, Charles P.
Lander, Eric S. https://orcid.org/0000-0003-2662-4631
Engreitz, Jesse M. https://orcid.org/0000-0002-5754-1719
- License Information
-
More Information
Article History
Received: 28 September 2021
Accepted: 17 May 2022
First Online: 20 May 2022
Competing interests
: C.P.F. is now an employee and shareholder of Bristol Myers Squibb. J.M.E. is a shareholder of Illumina, Inc, and other biotechnology companies. All other authors declare no competing interests.
